SCHEMBL22492928

SCHEMBL22492928

CCCCC(CCCC)C(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 9/20 0.73
CYP3A4 P08684 7/20 0.72
NR3C1 P04150 5/20 0.72
PGR P06401 5/20 0.72
TSHR P16473 5/20 0.72
NR1I2 O75469 4/20 0.72
AR P10275 4/20 0.72
MAPT P10636 4/20 0.72
CYP2C9 P11712 3/20 0.72
CYP2C19 P33261 2/20 0.72
CYP17A1 P05093 1/20 0.72
OPRK1 P41145 1/20 0.72
CYP19A1 P11511 3/20 0.68
PSEN1 P49768 1/20 0.61
PSEN2 P49810 1/20 0.61
APH1B Q8WW43 1/20 0.61
NCSTN Q92542 1/20 0.61
APH1A Q96BI3 1/20 0.61
PSENEN Q9NZ42 1/20 0.61
HSD17B10 Q99714 3/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16045649 0.92 LMNA (0.75) LMNACYP3A4NR3C1PGRTSHR
SCHEMBL5664295 0.89 LMNA (0.75) LMNACYP3A4NR3C1PGRTSHR
SCHEMBL5664622 0.89 LMNA (0.75) LMNACYP3A4NR3C1PGRTSHR
SCHEMBL24102582 0.88 LMNA (0.74) LMNACYP3A4NR3C1PGRTSHR
SCHEMBL6443765 0.88 LMNA (0.74) LMNACYP3A4NR3C1PGRTSHR
SCHEMBL6442894 0.87 CYP3A4 (0.80) LMNACYP3A4NR3C1PGRTSHR
SCHEMBL25863379 0.86 LMNA (0.77) LMNACYP3A4NR3C1PGRTSHR
SCHEMBL25863374 0.86 LMNA (0.77) LMNACYP3A4NR3C1PGRTSHR
SCHEMBL6445272 0.86 LMNA (0.77) LMNACYP3A4NR3C1PGRTSHR
SCHEMBL6445511 0.86 CYP3A4 (0.75) LMNACYP3A4NR3C1PGRTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11752102-B2 Powder preparation for nasal administration ASKA PHARMACEUTICAL CO., LTD. (JP) 2023-09-12 US disclosed
US-20220125716-A1 POWDER PREPARATION FOR NASAL ADMINISTRATION ASKA PHARMACEUTICAL CO., LTD. (JP) 2022-04-28 US disclosed
US-11234928-B2 Powder preparation for nasal administration ASKA PHARMACEUTICAL CO., LTD. (JP) 2022-02-01 US disclosed
US-20200360274-A1 POWDER PREPARATION FOR NASAL ADMINISTRATION ASKA PHARMACEUTICAL CO., LTD. (JP) 2020-11-19 US disclosed
EP-3718550-A1 POWDER PREPARATION FOR NASAL ADMINISTRATION ASKA Pharmaceutical Co., Ltd. (JP) 2020-10-07 EP disclosed
CN-111386119-A Powder nasal administration preparation ASKA制药株式会社 2020-07-07 CN disclosed